Cancer-control outcomes of Radium-223-pretreated lutetium- 177-PSMA radioligand vs. Radium- 223-naïve mCRPC patients - Wenzel, Mike; Theissen, Lena; Groener, Daniel; Kriegmair, Maximilian; Graefen, Markus; Maurer, Tobias; Salomon, Georg; Hoeh, Benedikt; Siech, Carolin; Banek, Severine; Chun, Felix K. H.; Mandel, Philipp (European journal of nuclear medicine and molecular imaging, 2025)
Gesehen am 01.07.2025